Evolving risk factors and predisposing conditions of Pneumocystis pneumonia in non-HIV patients: A seven-year multicenter study
Authors:
Open Access
- 14 August 2025
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 91 (3) , 106592
Abstract
No abstract availableKeywords
Funding Information
- National Taiwan University Hospital
- Ministry of Science and Technology, Taiwan (111-2314-B-002-201-MY3)
- National Science and Technology Council (NSTC 114-2314-B-002-270-MY3)
This publication has 36 references indexed in Scilit:
- Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying DiseaseChest, 2024
- Prophylaxis Against Pneumocystis jirovecii Pneumonia in AdultsJAMA, 2023
- Role of fungal burden in risk stratification of HIV-negative patients with Pneumocystis pneumonia: A 12-year, retrospective, observational, multicenter cohortInternational Journal of Infectious Diseases, 2023
- Risk factors for late-onset Pneumocystis jirovecii pneumonia in liver transplant recipientsInternational Journal of Infectious Diseases, 2023
- Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumoniaInternational Journal of Infectious Diseases, 2022
- Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective StudyInfectious Diseases and Therapy, 2021
- Fungal Infections Associated With the Use of Novel Immunotherapeutic AgentsCurrent Clinical Microbiology Reports, 2020
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)Clinical Microbiology and Infection, 2018
- Infections in Cancer Patients with Solid Tumors: A ReviewInfectious Diseases and Therapy, 2017
- The immune system and hypertensionImmunologic Research, 2014